Diversified Trust Co Invests $345,000 in Heartflow, Inc. $HTFL

Diversified Trust Co bought a new stake in Heartflow, Inc. (NASDAQ:HTFL) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 14,200 shares of the company’s stock, valued at approximately $345,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd acquired a new position in Heartflow in the fourth quarter valued at approximately $27,000. Russell Investments Group Ltd. acquired a new position in shares of Heartflow in the 4th quarter valued at $45,000. Legal & General Group Plc purchased a new position in shares of Heartflow in the 3rd quarter valued at $59,000. Strs Ohio acquired a new stake in Heartflow during the 4th quarter worth $99,000. Finally, Police & Firemen s Retirement System of New Jersey purchased a new stake in Heartflow in the fourth quarter valued at $131,000.

Insiders Place Their Bets

In other news, major shareholder Bain Capital Life Sciences Inv sold 948,757 shares of the firm’s stock in a transaction on Thursday, April 30th. The stock was sold at an average price of $29.23, for a total transaction of $27,732,167.11. Following the transaction, the insider directly owned 8,448,158 shares of the company’s stock, valued at approximately $246,939,658.34. This trade represents a 10.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO John C.M. Farquhar sold 38,900 shares of the stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $35.00, for a total value of $1,361,500.00. Following the transaction, the chief executive officer directly owned 457,935 shares of the company’s stock, valued at approximately $16,027,725. The trade was a 7.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 2,180,338 shares of company stock valued at $64,012,598. Company insiders own 7.70% of the company’s stock.

Heartflow Price Performance

Shares of NASDAQ HTFL opened at $35.68 on Friday. The firm’s 50-day moving average is $30.69 and its two-hundred day moving average is $28.60. The company has a market capitalization of $3.08 billion and a PE ratio of -11.47. Heartflow, Inc. has a 12-month low of $20.13 and a 12-month high of $41.22.

Heartflow (NASDAQ:HTFL) last announced its earnings results on Thursday, May 14th. The company reported ($0.16) EPS for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.08. The company had revenue of $52.59 million for the quarter. The business’s revenue was up 41.3% on a year-over-year basis. On average, analysts forecast that Heartflow, Inc. will post -0.82 EPS for the current fiscal year.

Wall Street Analyst Weigh In

HTFL has been the topic of a number of research analyst reports. Piper Sandler reiterated an “overweight” rating on shares of Heartflow in a research report on Thursday, June 11th. William Blair initiated coverage on Heartflow in a research report on Monday, May 4th. They set an “outperform” rating on the stock. JPMorgan Chase & Co. reduced their price objective on Heartflow from $40.00 to $35.00 and set an “overweight” rating for the company in a research note on Thursday, March 19th. Weiss Ratings upgraded shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, June 12th. Finally, Wells Fargo & Company lifted their target price on shares of Heartflow from $35.00 to $37.00 and gave the company an “overweight” rating in a report on Friday, May 15th. Six equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $37.00.

Heartflow Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.